1. Home
  2. AURA vs RPAY Comparison

AURA vs RPAY Comparison

Compare AURA & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • RPAY
  • Stock Information
  • Founded
  • AURA 2007
  • RPAY 2006
  • Country
  • AURA United States
  • RPAY United States
  • Employees
  • AURA N/A
  • RPAY N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • RPAY Business Services
  • Sector
  • AURA Health Care
  • RPAY Consumer Discretionary
  • Exchange
  • AURA Nasdaq
  • RPAY Nasdaq
  • Market Cap
  • AURA 396.8M
  • RPAY 387.2M
  • IPO Year
  • AURA 2021
  • RPAY N/A
  • Fundamental
  • Price
  • AURA $6.56
  • RPAY $4.73
  • Analyst Decision
  • AURA Strong Buy
  • RPAY Buy
  • Analyst Count
  • AURA 6
  • RPAY 9
  • Target Price
  • AURA $22.33
  • RPAY $8.06
  • AVG Volume (30 Days)
  • AURA 217.2K
  • RPAY 1.2M
  • Earning Date
  • AURA 08-07-2025
  • RPAY 08-07-2025
  • Dividend Yield
  • AURA N/A
  • RPAY N/A
  • EPS Growth
  • AURA N/A
  • RPAY N/A
  • EPS
  • AURA N/A
  • RPAY N/A
  • Revenue
  • AURA N/A
  • RPAY $309,647,000.00
  • Revenue This Year
  • AURA N/A
  • RPAY N/A
  • Revenue Next Year
  • AURA N/A
  • RPAY $8.40
  • P/E Ratio
  • AURA N/A
  • RPAY N/A
  • Revenue Growth
  • AURA N/A
  • RPAY 2.26
  • 52 Week Low
  • AURA $4.35
  • RPAY $3.59
  • 52 Week High
  • AURA $12.38
  • RPAY $10.16
  • Technical
  • Relative Strength Index (RSI)
  • AURA 53.66
  • RPAY 47.31
  • Support Level
  • AURA $6.37
  • RPAY $4.76
  • Resistance Level
  • AURA $6.79
  • RPAY $4.96
  • Average True Range (ATR)
  • AURA 0.37
  • RPAY 0.16
  • MACD
  • AURA 0.01
  • RPAY -0.02
  • Stochastic Oscillator
  • AURA 60.72
  • RPAY 23.16

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About RPAY Repay Holdings Corporation

Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.

Share on Social Networks: